2024-07-29 09:51:59
A few days ago a treatment to prevent AIDS was proposed. “This is an important turning point in the fight against HIV,” said Yazdan Yazdanpanah, an infectious disease expert at France’s Inter Milan.
Published on 07/29/2024 11:51
Reading time: 1 minute Yazdan Yazdanpanah, Director of Emerging Infectious Diseases at ANRS, speaks at Inter Milan, France, on July 29, 2024.
An antiretroviral drug from Gilead Labs in the United States has been shown to prevent HIV. Now, “The fight for access to this treatment and its price”Yazdan Yazdanpanah, Director of Emerging Infectious Diseases at ANRS, announced on France Internationale TV on Monday 29 July. This battle must be fought by “Everyone, community members, doctors, policymakers”.
How much does it cost to come to Napawe »expensive”The professor who specializes in infectious diseases emphasized that it is $40,000 per person per year. Prices for generic drugs could drop by about $40, according to estimates revealed by researchers at the 25th International AIDS Conference.
A few days ago a treatment to prevent AIDS was proposed. “This is an important turning point in the fight against HIV, and we have made great progress in recent years,” said Yazdan Yazdanpanah, an infectious disease expert.#le69Inter Milan pic.twitter.com/KVHJ0zvEQN
— France Inter Milan (@franceinter) July 29, 2024
“Today, this therapy is also used to treat patients, and in very advanced treatment lines, which is why it is very expensive.””, explains Yazdan Yazdanpanah. The High Authority for Health clearly states on its website that Sunlenca (the commercial name of lenacapavir) “The last option”when other treatments don’t work.
Gilead a “Start working with generic drug manufacturers to try to make this treatment available to everyone””, assures Yazdan Yazdampana. Its peculiarity is that it has a “Very efficient”. Most importantly, its management is due to “Injections twice a year and once every six months”What “Better adherence to treatment than daily treatment”.
Can we talk about the HIV vaccine? “This is a debate between us [les chercheurs]“he replied. “It’s almost a vaccine, but it’s not a vaccine. With a vaccine, you get a shot and then you don’t do anything. With the flu, it’s once a year.”, he replied. Together with Napawe, “We still need to follow the people who receive it to see if it is well tolerated and if there are no infections”, he explained. for this reason, “A little different”.
1722280886
#ANRS #director #confirms #battle #begins #obtain #access #promising #treatment #price